In vitro evolution and analysis of HIV-1 LTR-specific recombinases
- PMID: 20600935
- DOI: 10.1016/j.ymeth.2010.06.014
In vitro evolution and analysis of HIV-1 LTR-specific recombinases
Abstract
Current antiretroviral therapies would greatly benefit from the concurrent removal of integrated HIV-1 proviral DNA from the patient's cells. In this review, we describe an experimental strategy that allowed the engineering and functional analysis of a HIV-1 LTR-specific recombinase (Tre-recombinase). We furthermore provide protocols that are utilized for the investigation of Tre's antiretroviral activity in infected tissue cultures as well as in infected humanized Rag2(-/-)γc(-/-) mice.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase.PLoS One. 2012;7(2):e31576. doi: 10.1371/journal.pone.0031576. Epub 2012 Feb 13. PLoS One. 2012. PMID: 22348110 Free PMC article.
-
Molecular evolution of the tre recombinase.J Vis Exp. 2008 May 29;(15):791. doi: 10.3791/791. J Vis Exp. 2008. PMID: 19066582 Free PMC article.
-
HIV-1 proviral DNA excision using an evolved recombinase.Science. 2007 Jun 29;316(5833):1912-5. doi: 10.1126/science.1141453. Science. 2007. PMID: 17600219
-
Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice.PLoS Pathog. 2013;9(9):e1003587. doi: 10.1371/journal.ppat.1003587. Epub 2013 Sep 26. PLoS Pathog. 2013. PMID: 24086129 Free PMC article.
-
Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells.J Antimicrob Chemother. 2010 Mar;65(3):434-7. doi: 10.1093/jac/dkp473. Epub 2010 Jan 5. J Antimicrob Chemother. 2010. PMID: 20051476
Cited by
-
Editing out HIV: application of gene editing technology to achieve functional cure.Retrovirology. 2021 Dec 18;18(1):39. doi: 10.1186/s12977-021-00581-1. Retrovirology. 2021. PMID: 34922576 Free PMC article. Review.
-
Engineering altered protein-DNA recognition specificity.Nucleic Acids Res. 2018 Jun 1;46(10):4845-4871. doi: 10.1093/nar/gky289. Nucleic Acids Res. 2018. PMID: 29718463 Free PMC article. Review.
-
Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA.Nucleic Acids Res. 2017 Sep 19;45(16):9726-9740. doi: 10.1093/nar/gkx603. Nucleic Acids Res. 2017. PMID: 28934476 Free PMC article.
-
RNA interference approaches for treatment of HIV-1 infection.Genome Med. 2015 May 28;7(1):50. doi: 10.1186/s13073-015-0174-y. eCollection 2015. Genome Med. 2015. PMID: 26019725 Free PMC article.
-
The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.Viruses. 2019 Mar 13;11(3):255. doi: 10.3390/v11030255. Viruses. 2019. PMID: 30871200 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical